In conclusion, our analysis of the effect of potential modulators of SPDEF and FOXA1 activity in ER+ breast cancer suggests that MINDy and other such computational tools have the power to identify valid modulators of TF activity that warrants further follow-up work. This evidence concerns the gene TF and breast carcinoma.